Anthony T. Yachnis, M.D.
Associate Professor, Chief of Neuropathology
Department of Pathology, Immunology and Laboratory Medicine
University of Florida College of Medicine
Gainesville, Florida

Publications
       
      1. Yachnis AT. Cerebellar Heterotopia and Dysplasia. In: Pediatric Neuropathology,
        B Harding, J Golden, Eds., International Society of Neuropathology, ISN Neuropathology Press, Basel, Switzerland (In Press, 2004)
      2. Roper, SN, Yachnis AT. Neuronal Heterotopia in Temporal Lobe Epilepsy: An Epiphenomenon. In: Issues and Controversies in Epilepsy Surgery, JW Miller, DL Silbergeld, Eds., Marcel Dekker, Inc., New York, NY (In Press, Fall 2004)
      3. Yachnis AT. Vascular Diseases. In: Foundations in Diagnostic Pathology - Neuropathology, RA Prayson Ed., Foundations in Neuropathology series, Elsevier, Philadelphia, PA (In Press)
      4. Yachnis AT, Baker HV. Applications of Gene Expression Profiling to the Study of Malignant Gliomas. In: Runge M, Patterson C, eds. The Principles of Molecular Medicine, Second Edition. Totowa, NJ, USA: Humana Press (In Press)
      5. Rosenblum M, Yachnis AT. Lhermitte-Duclos Disease. In: Bigner DD, McLendon RE, Bruner JM, eds. Russell and Rubinstein’s Pathology of Tumors of the Nervous System, Seventh Edition. New York: Oxford University Press (In preparation)
      6. Yachnis AT. Hemangioblastoma. In: Bigner DD, McLendon RE, Bruner JM, eds. Russell and Rubinstein’s Pathology of Tumors of the Nervous System, Seventh Edition. New York: Oxford University Press (In preparation)
      7. Yachnis AT, Mescher AL: Stimulation of DNA synthesis in BALB/c 3T3 cells by peripheral nerve degenerating in vitro. Exp Neurol 76:139-149, 1982.
      8. Yachnis AT. Mitogenic effect of myelinated versus unmyelinated garfish nerve extracts. Brain Res 253:349-352, 1982.
      9. Yachnis AT, Crawley RT, Jensen M, McGrane M, Moody T. The antagonism of bombesin in the CNS by substance P analogues. Life Sci 35:1963-1969, 1984.
      10. Yachnis AT, Trojanowski JQ, Memmo M, Schlaepfer WW. Expression of neurofilament proteins in the hypertrophic granule cells of Lhermitte-Duclos disease: an explanation for the mass effect and the myelination of parallel fibers in the disease state. J Neuropath Exp Neurol 47:206-216, 1988.
      11. Korat O, Yachnis AT, Ernst CS. Cytologic detection of amyloid in duodenal and ureteral brushings. Diag Cytopathol 4:133-136, 1988.
      12. Raps EC, Galetta SL, King Jr JT, Yachnis AT, Flamm ES. Isolated one-and-a half syndrome with pontine cavernous angioma: successful surgical removal. J Clin Neuroophthal 10(4):287-290, 1990.
      13. Cohen JA, Yachnis AT, Arai M, Davis JG, Scherer SS. Expression of the neu protooncogene by Schwann cells during peripheral nerve development and Wallerian degeneration. J Neurosci Res 31:622-634, 1992.
      14. Yachnis AT, Rorke LB, Biegle JA, Zimmerman RA, Perilongo G, Sutton L. Desmoplastic primitive neuroectodermal tumor of divergent differentiation: broadening the spectrum of desmoplastic infantile neuroepithelial tumors. Am J Surg Pathol 16:998-1006, 1992.
      15. Mourelatos Z, Yachnis AT, Rorke LB, Mikol J, Gonatas NK. On the "fragmentation" of the golgi apparatus of neurons in amyotrophic lateral sclerosis, other motor neuronopathies, and in one case of mitochondrial myopathy with cytochrome C oxidase deficiency. Ann Neurol 33:608-615, 1993.
      16. Shaver E, Rabsemen S, Yachnis AT, Sutton L. Sinus histiocytosis with massive lymphadenopathy: extranodal presentation in the cavernous sinus of a four year old boy.
        J Neurosurg 79:769-773, 1993.
      17. Torres C, Yachnis AT, Rebsamen S. Ganglioglioma. Med Pediatr Oncol 21:511-516, 1993.
      18. Yachnis AT, Rorke LB, Lee VMY, Trojanowski JQ. Expression of neuronal and glial polypeptides during histogenesis of the human cerebellar cortex including observations on the dentate nucleus. J Comp Neurol 334:356-369, 1993.
      19. Trojanowski JQ, Fung KM, Rorke LB, Tohyama T, Yachnis AT, Lee VMY. In vivo and in vitro models of medulloblastomas and other primitive neuroectodermal brain tumors of childhood. Molec Chem Neuropathol 21:219-238, 1994.
      20. Sinson G, Sutton LN, Yachnis AT, Duhaime AC, Schut L. Subependymal giant cell
        astrocytoma in children. Pediatr Neurosurg 20:233-239, 1994.
      21. Yachnis AT, Rorke LB, Trojanowski JQ. Cerebellar dysplasias in humans: development and possible relationship to glial and primitive neuroectodermal tumors of the cerebellar vermis. J Neuropathol Exp Neurol 63:61-71, 1994.
      22. Duhaime AC, Gennarelli LM, Yachnis AT. Acute subdural hematoma: is the blood toxic itself? J Neurotrauma 11:669-678, 1994.
      23. Yachnis AT, Trojanowski JQ. Studies of childhood brain tumors using immunohistochemistry and microwave technology: methodological considerations.
        J Neurosci Meth 55:151-200, 1994.
      24. Janss A, Hiehle JF, Yachnis AT. Neurofibromatosis type I. Med Pediatr Oncol 25:213-222, 1995.
      25. Manhoff DT, Rorke LB, Yachnis AT. Primary intracranial atypical teratoid/rhabdoid tumor in a child with Canavan disease. Pediatr Neurosurg 22:214-222, 1995.
      26. Powell SZ, Yachnis AT, Rorke LB, Rojiani AR, Eskin TA. Divergent differentiation in pleomorphic xanthoastrocytoma: evidence for a neuronal element and possible relationship to ganglion cell tumors. Am J Surg Pathol 20:379-387, 1995.
      27. DiPaolo DP, Zimmerman RA, Rorke LB, Zackai EH, Bilaniuk LT, Yachnis AT. Neurofibromatosis type I: pathologic substrate of high signal foci in the brain.
        Radiology 195:721-724, 1995.
      28. Mitchell D, Rojiani AM, Richards D, Yachnis AT, Powell SZ. Congenital CNS primitive neuroectodermal tumor: case report and review of the literature. Pediatr Pathol Lab Med 15:949-956, 1995.
      29. Molloy P, Sutton L, Yachnis AT, Rabsamen S. Brainstem neoplasms. Med Pediatr Oncol 24:379-387, 1995.
      30. Yachnis AT, Berg J, Martinez-Salazar A, Bender BS, Diaz L, Rojiani AM, Eskin TA, Orenstein JM. Disseminated microsporidiosis involving the CNS, heart, and kidneys: report of a newly recognized pansporoblastic species in two symptomatic AIDS patients. Am J Clin Pathol 106:535-543, 1996.
      31. Molloy PT, Yachnis AT, Rorke LB, Dattilo JJ, Needle M, Millar W, Goldwein JW, Sutton L, Phillips PC. Central nervous system medulloepithelioma: a series of eight cases including two arising in the pons. J Neurosurg 84:430-436, 1996.
      32. Janss AJ, Yachnis AT, Silber JH, Perolongo G, Molenaar WM, Rorke LB, Lee VMY, Trojanowski JQ, Tohyama T, Sutton LN, Lange B, Phillips PC. Glial differentiation predicts poor clinical outcome in primitive neuroectodermal tumor-medulloblastoma.
        Ann Neurol 39:481-489, 1996.
      33. Adair JC, Schwartz RL, Eskin TA, Yachnis AT, Heilman KM. Rapidly progressive dementia: Clinicopathologic correlation. J Geriatr Psychiat Neurol 9:209-213, 1996.
      34. Yachnis AT, Powell SZ, Olmsted JJ, Eskin TA. Distinct neurodevelopmental patterns of bcl-2 and bcl-x polypeptide expression are altered in glioneuronal hamartias of the temporal lobe. J Neuropathol Exp Neurol 56:180-192, 1997.
      35. Orenstein JM, Gaetz HP, Yachnis AT, Frankel SS, Mertens RB, Didier ES. Disseminated microsporidiosis in AIDS: are any organs spared? AIDS 11:385-386, 1997.
      36. Perry A, Giannini C, Scheithauer BW, Rojiani AM, Yachnis AT, Seo IS, Johnson PC, Kho J, Shapiro S. Composite pleomorphic xanthoastrocytoma and ganglioglioma: report of four cases and review of the literature. Am J Surg Pathol 21:763-771, 1997.
      37. Maria BL, Hoang KBN, Tusa RJ, Mancuso AA, Hamed LM, Quilsing RG, Hove MT, Fennell EB, Booth-Jones M, Ringdahl DM, Yachnis AT, Creel G, Frerking B. "Joubert syndrome" revisited: key ocular motor signs with MRI correlation. J Child Neurol 12:423-430, 1997.
      38. Yachnis AT. Neuropathology of pediatric brain tumors. Semin Pediatr Neurol 4:282- 291, 1997.
      39. Yachnis AT, Giovanini MA, Eskin TA, Reier PJ, Anderson DK. Developmental patterns of bcl-2 and bcl-x polypeptide expression in the human spinal cord. Exp Neurol 150:82-97, 1998.
      40. Vavra J, Yachnis AT, Shadduck JA, Orenstein JM. Microsporidia of the genus Trachipleistophora - causative agents of human microsporidiosis: Description of Trachipleistophora anthropophthera N. Sp. (Protozoa: Microsporidia). J Eukaryot Microbiol 45:273-283, 1998.
      41. Vavra J, Yachnis AT, Canning EU, Curry A, Shadduck JA, Orenstein JM. A Trachipleistophora-like microsporidium of man: its dimorphic nature and relationship to Thelohania apodemi. Folia Parasitologica 45:157-162, 1998.
      42. Juul SE, Yachnis AT, Christensen RD. The tissue distribution of Epo and Epo-R in the developing human fetus. Early Human Devel 52:235-249, 1998.
      43. Yachnis AT, Neubauer D, Muir D. Characterization of a primary central nervous system atypical teratoid/rhabdoid tumor and derivative cell line: immunophenotype and neoplastic properties. J Neuropathol Exp Neurol 57:961-971, 1998.
      44. Yachnis AT, Faunce WH, Glasser RS, Fessler RG. An ossifying fibromyxoid tumor of the dura: microcystic meningioma in disguise? Neuro-Orthopedics 24:13-19, 1998.
      45. Juul SE, Yachnis AT, Rojiani AM, Christensen RD. Immunohistochemical localization of erythropoietin and its receptor in the developing human brain. Pediatr Devel Pathol 2:148- 158, 1999.
      46. Maria-BL, Quisling-RG, Rosainz LC, Yachnis AT, Gitten J, Dede D, Fennell-E. Molar tooth sign in Joubert syndrome: clinical, radiologic, and pathologic significance.
        J Child Neurol 14:368-76, 1999.
      47. Yachnis AT, Rorke LB. Cerebellar and brainstem development: An overview in relationship to Joubert syndrome. J Child Neurol 14:570-573, 1999
      48. Yachnis AT, Rorke LB. Neuropathology of Joubert syndrome. J Child Neurol 14:655-659, 1999.
      49. Yachnis AT, Roper SN, Love A, Fancey JT, Muir D. Bcl-2 immunoreactive cells with immature neuronal phenotype exist in the non-epileptic adult human brain. J Neuropathol Exp Neurol 59:113-119, 2000.
      50. Lu L, Wilkinson EJ, Yachnis AT. CSF cytology of atypical teratoid/rhabdoid tumor of the brain: a case report. Diagnostic Cytopathol 23:329-332, 2000.
      51. Muir D, Neubauer D, Lim I, Yachnis AT, Wallace M. Tumorigenic properties of neurofibroma-deficient neurofibroma Schwann cells. Am J Pathology 158:501-513, 2001.
      52. Knapik J, Yachnis AT, Ripley D, Biegel JA, Rathor S, Hardt NS, Talerman A, Wilkinson EJ. Aggressive uterine sarcoma with rhabdoid features: diagnosis by peritoneal cytology and absence of INI1 gene mutation by FISH. Human Pathol 32:884-886, 2001.
      53. Yachnis AT. Rhombencephalosynapsis with massive hydrocephalus: case report and pathogenetic considerations. Acta Neuropathol 103:301-304, 2002.
      54. Roper S, Yachnis AT. Cortical dysgenesis and epilepsy. The Neuroscientist 8:358-373, 2002
      55. Rossi FH, Okun M, Yachnis AT, Quisling R, Triggs WJ. Corticosteroid treatment in mitochondrial encephalopathies. The Neurologist 2002 Sep;8(5):313-5.
      56. Yachnis AT. Intra-operative consultation for nervous system lesions. Semin Diagn Pathol 19:192-206, 2002.
      57. Padgett KR, Maria BL, Yachnis AT, Blackband SJ. Ex vivo high resolution MRI of the brain in Joubert syndrome. J Child Neurol 17:910-912, 2003.
      58. Martinez-Diaz, H, Kleinschmidt-DeMasters BK, Powell SZ, Yachnis AT. Giant cell glioblastoma and pleomorphic xanthoastrocytoma show distinct immunohistochemical profiles for neuronal antigens and TP53 but share common reactivity for class III b tubulin.
        Arch Pathol Lab Med 127:1187-1191, 2003.
      59. Werner D, Wilkinson EJ, Ripley D, Yachnis AT. Primary adenocarcinoma of the vagina with mucinous-enteric differentiation. A report of two cases with associated vaginal adenosis without history of DES exposure. J Dis Lower Gen Tract 8:38-42, 2004.
      60. Ulm AJ, Yachnis AT, Brat DJ, Rhoton A. Pituicytoma: A report of two cases with clinicopathologic correlation and histogenetic perspective. Neurosurgery 54:753-7, 2004. discussion 757-8.
      61. Cogle CR, Yachnis AT, Laywell ED, Zander DS, Wingard JR, Steindler DA, Scott EW. Bone marrow transdifferentiation in brain after transplantation: a retrospective study. Lancet. 363(9419):1432-1437, 2004
        Journal Articles (continued):
      62. Katz T, Amdur R, Yachnis AT, Mendenhall WM. Pushing the limits of radiotherapy for atypical meningioma. Am J Clin Oncol (In press).

       

    Top of page

      ABSTRACTS: (in chronological order)

    1. Bockman EL, Steffen RP, McKenzie JE, Yachnis AT, Haddy FJ. Adenosine and active hyperemia in dog gracilis muscle. Fed Proc 41: 1680-1680, 1982
    2. Steffen RP, McKenzie JE, Yachnis AT, et al. The effect of acetate on skeletal-muscle adenosine, resistance and oxygen-consumption. Fed Proc 41 (5): 1681-1681, 1982
    3. Yachnis AT, Cohen JA: Expression of the neu gene in developing peripheral nerves and peripheral nerve tumors. UCLA Symposia on Molecular and Cellular Biology, South Padre Island, TX, April 18, 1990. J Cell Biochem 14F (Suppl):57, 1990.
    4. Yachnis AT, Rorke LB, Biegle JA, Zimmerman RA, Perilongo G, Sutton L: "Desmoplastic primitive neuroectodermal tumor of childhood." J Neuropathol Exp Neurol 50:292, 1991
    5. Arai M, Brooks SA, Yachnis AT, Prak EL, Prystowsky MB, Cohen JA. A novel interleukin-2 responsive gene selectively expressed by mature neurons and proliferating lymphocytes. Neurology 41:1162, 1991.
    6. Zimmerman RA, Yachnis AT, Rorke LB, et al. Pseudostatus marmoratus. Radiology 185:123 Suppl., 1992.
    7. Yachnis AT, Rorke LB, Lee VMY, Trojanowski JQ: "Developmental Expression of Neuronal and Glial Molecules in the Human Cerebellum." American Association of Neuropathologists Annual Meeting, Salt Lake City, UT, June 10, 1993. J Neuropathol Exp Neurol, 52:285, 1993.
    8. Janss AJ, Yachnis AT, Silber JH, Perilongo G, Molenaar WM, Rorke LB, Lee VMY, Trojanowski JQ, Tohyama T, Sutton LN, Lange B, Phillips PC: Expression of neuronal
      and/or glial intermediate filament protein antigens in medulloblastoma: Relationship to disease-free survival. Ann Neurol 34:469, 1993.
    9. Duhaime AC, Gennarelli L, Yachnis AT, Ross DT. Experimental acute subdural hematoma: variations on a theme. Second International Trauma Sumposium. Glasgow.
      J Neurotrauma 10:S150, 1993.
    10. DiPaolo DP, Zimmerman RA, Rorke LB, Yachnis AT: Radiologic-pathologic correlation of high signal foci in neurofibromatosis, type 1. Presented at the annual meeting of the Radiologic Society of North America, 1994. Radiology 191P:316, 1994.
    11. Powell SZ, Yachnis AT, Eskin TA. Divergent differentiation in pleomorphic xanthoastrocytoma: evidence for a "glioneuronal element and possible relationship to ganglioglioma and related tumors. Brain Pathol 4:433, 1994.
    12. Legarda S, Yachnis AT, Gilmore R, Mickle P, Ringdahl D, Maria B. Pathology and outcome following lesionectomy in 11 children with temporal lobe lesions and epilepsy:
      A retrospective study. Epilepsia 35(S8): 139, 1994.
    13. Powell SZ, Yachnis AT, Eskin TA. Expression of the bcl-2 protooncogene during human temporal lobe development and in indolent neoplasm/hamartomas resected from patients with intractable epilepsy. Presented at the College of American Pathologists Meeting, Orlando, FL, April 24, 1995.
    14. Yachnis AT, Powell SZ, Eskin TA. Developmental expression of bcl-2 in the human temporal lobe. Presented at the "International Symposium on Oxidative Stress, Apoptosis, and Brain Damage". Published in Symposium Proceedings, University of Pittburgh, Pittsburgh, PA, September 21-24, 1995.
    15. Maria BL, Tusa RJ, Hoang KBN, Mancuso AA, Hamed LM, Quisling RG, Ringdahl DM, Hove MT, Yachnis AT. "Joubert" syndrome revisited: key ocular motor signs with MRI correlation. Presented at the "Child Neurology Society, 24th Annual Meeting", October 1995. Ann Neurol 38:515, 1995.
    16. Janss AJ, Yachnis AT, Silber JH, Rorke LB, Trojanowski JQ, Lee VMY, Phillips PC. Differentiation along glial lines predicts poor outcome in primitive neuroectodermal tumors (medulloblastomas). Presented at the "Child Neurology Society, 24th Annual Meeting", October 1995. Ann Neurol 38:549, 1995.
    17. Powell SZ, Eskin TA, Yachnis AT. Bcl-2 like immunoreactivity identifies distinct cell populations in ependymal and astroglial neoplasms. Presented at the U.S. and Canadian Academy of Pathology Meeting, Washington DC, 03-96. Lab Invest 74:142A, 1996.
    18. Yachnis AT, Bender BS, Martinez-Salazar A, Berg J, Rojiani AM, Eskin TA, Orenstein JM. Central nervous system microsporidiosis in acquired immunodeficiency syndrome: a report of two cases. Presented at the U.S. and Canadian Academy of Pathology Meeting, Washington DC, March 27, 1996. Lab Invest 74:133A, 1996.
    19. Sessions R, Yachnis AT, Eskin TA. Bcl-2 expression in the normal human adenohypophysis and in pituitary adenomas. Presented at the AANP Annual Meeting, Vancouver BC, June 1996, J Neuropathol Exp Neurol 55:627, 1996.
    20. Yachnis AT, Eskin TA. Distinct developmental programs of bcl-2 and bcl-x are altered in glioneuronal "hamartomas" of the temporal lobe. Presented at the American Association of Neuropathologists Annual Meeting, Vancouver BC, June, 1996. J Neuropathol Exp Neurol 55:630, 1996. Won the AANP Moore Award
    21. Orenstein JM, Yachnis AT, Didier E, Fishbein M, Mertens R. Microspondia also infect the brain and heart of AIDS patients. Presented by Dr. Orenstein In: Vol. 2 of the XI International Conference on AIDS, Vancouver BC, July 7-12 1996, page 265.
    22. Maria BL, Quisling RG, Yachnis AT, Hoang KBN, Tusa RJ, Hamed LM. "Joubert syndrome": First rhombencephalic segmentation abnormality? Presented at the "Child Neurology Society, 24th Annual Meeting", October 1996. Ann Neurol 40:297, 1996.
    23. Roper SN, Eskin TA, King MA, Yachnis AT, Gilmore RL. Dual pathology in patients with temporal lobe epilepsy and developmental abnormalities. Presented by Dr. Roper at the American Association of Neurological Surgeons annual meeting, Denver, CO., April, 1997.
    24. Yachnis AT, Roper SN, Eskin TA. Bcl-2 and bcl-x immunoreactivity in hippocampal sclerosis associated with temporal lobe epilepsy. J Neuropathol Exp Neurol 56:600, 1997.
    25. Juul SE, Yachnis AT, Rojiani AM, Christensen RD. Immunohistochemical localization of erythropoietin (EPO) and erythropoietin receptor (EPO-R) in the developing human brain. Presented by Dr. Juul at the American Pediatric Society / The Society for Pediatric Research annual meeting, Washington, D.C., May, 1997. Pediatr Res 41:47A, 1997.
    26. Gilmore R, Roper S, Yachnis AT, Eskin T, Quisling R. Increased hippocampal T2 relaxation time in TLE: Does it mean hippocampal sclerosis? Epilepsia 38 (S8), 141, 1997.
    27. Vavra J, Yachnis AT, Shadduck JA, Orenstein JM, Canning EU, Curry A. A Trachipleistophora-like microsporidium of man: its dimorphic nature and relationship to Thelohania apodemi. Presented by Dr. Vavra at the Second Workshop on Microsporidiosis and Cryptosporidiosis in Immunodeficient Patients, July, 1997. Electronic publication:
      http://www.paru.cas.cz/workshop/workshop.htm
    28. Juul SE, Yachnis AT, Christensen RD. Tissue distribution of erythropoietin (EPO) and its receptor (EPO-R) in the developing human fetus. Presented by Dr. Juul at the American Pediatric Society / The Society for Pediatric Research, 1998 annual meeting.
      Abstracts (contiued)
    29. Yachnis AT, Fancey JT, Eskin TA. Bcl-2 immunostaining identifies hamartias of the caudal amygdala in non-epileptic patients. J Neuropathol Exp Neurol 57:514, 1998.
    30. Yachnis AT, Love A, Roper SN, Muir D. Cells with features of immature post-mitotic neurons exist in the adult human brain. J Neuropathol Exp Neurol 58:519, 1999.
    31. Yachnis AT. Rhombencephalosynapsis with massive congenital hydrocephalus: case report and pathogenetic hypothesis. J Neuropathol Exp Neurol 59:450, 2000.
    32. Martinez-Diaz H, Kleinschmidt-DeMasters BK, Powell SZ, Yachnis AT. Neuronal antigens and p53 in giant cell gliomas. J Neuropathol Exp Neurol 59:438, 2000.
    33. Yachnis AT. Class III beta tubulin immunoreactivity in gliomas. J Neuropathol Exp Neurol 60:517, 2001.
    34. Yachnis AT, Friedman WA, Lopez MC, and Baker HV. Contrasting gene expression profiles in glioblastoma multiforme versus anaplastic oligodendroglioma. J Neuropathol Exp Neurol 61:474, 2002.
    35. Pincus DW, Ignatova TN, Kukekov VG, Yachnis AT, Steindler DA. Isolation of clonogenic cells from pediatric brain tumors. Neurosurgery 51 (2): 771, 2002.
    36. Yachnis AT, Friedman WA, Lopez MC, and Baker HV. Genomic expression profiling identifies CD44 as a marker for distinguishing glioblastoma multifome from lower-grade gliomas. Oncogenomics Meeting, Jan. 2003.
    37. B.L. Jordan, R. Marsh, A.T. Yachnis. Novel Anti-Pineal Gland Antibodies Distinguish Subtypes of Primary Pineal Parenchymal Tumors. Joint Cancer Conference of the Florida Universities. Feb. 21, 2003.
    38. Yachnis AT, Perry A, Lopez MA, Friedman WA, Baker HV. Gene expression profiling identifies clinically relevant glioma subtypes and possible targets for therapy. J Neuropathol Exp Neurol 62:542, 2003.
    39. Kearns S, Toussaint N, Scheffler B, Mandel R, Steindler D, Sullivan S, Yachnis AT. CD44s expression patterns of infiltrating gliomas: a “gray matter”. J Neuropathol Exp Neurol 63:540, 2004
    40. Tu PH, Giannini C, Burack R, O’Neill BP, Yachnis AT, Perry A. Marginal zone lymphoma (“MALToma”) of the CNS: a clinicopathologic and genetic series of 7 cases. J Neuropathol Exp Neurol 63:518, 2004
    41. Biegel JA, Burger PC, Hamilton RL, Kleinschmidt-DeMasters B, Perry A, Pomeroy S, Rosenblum MK, Yachnis AT, Rorke LB, Judkins AR. Inactivation of INI1 distinguishes CNS rhabdoid tumor from choroid plexus carcinoma. Cytogenetic and Genome Research (In press)

         Return to:  Top of page | Dr. Yachnis's home page